Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Nucleoproteins – e.g. – chromatin – chromosomal proteins,...
Patent
1991-11-05
1994-09-27
Nucker, Christine M.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Nucleoproteins, e.g., chromatin, chromosomal proteins,...
530350, 435974, 930221, A61K 3710
Patent
active
053508351
ABSTRACT:
The invention relates to a cellular protein which is specific and has high affinity for nucleic acid sequences characteristic of an intact TAR RNA loop sequence of the HIV LTR TAR region. The invention also relates to a between 1,000-10,000-fold purified, about 185 kD protein preparation isolated from a mammalian cell nuclear extract preparation, most specifically a HeLa cell extract. The about 185 kD protein is shown to regulate HIV viral gene expression by binding a TAR RNA region of an HIV LTR template, in the presence of a cofactor fraction (including at least a.about.100 kD cofactor), and a tat protein. The TRP-185, having a molecular weight of about 185 kD protein may also provide a research tool in the study of viral and cellular gene expression. A route for the development of immunodiagnostics for AIDS and related disorders may also be provided given the specific and high affinity of TRP-185 for HIV RNA. The 185 kD protein and related encoding amino acid and DNA sequences may also be used in therapeutic agents for AIDS and related disorders and, for the generation of specific antibodies for use in the diagnosis and study of the epidemiology of AIDS.
REFERENCES:
Wu et al tat Regulates Bonding of the HIV . . . TRP-185 (reference AR) Genes & Development 5:2128-2140 1991.
Garcia et al. (1989), The EMBO Journal, 8(3):765-778, Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation.
Marciniak et al. (1990), Cell, 63:791-802, HIV-1 TAT Protein Trans-Activates Transcription In Vitro.
Berkhout et al. (1989), Cell, 59:273-282, Tat Trans-Activates the Human Immunodeficiency Virus Through a Nascent RNA Target.
Laspia et al. (1990), Genes & Development, 4:2397-2408, Synergy between HIV-1 Tat and adenovirus E1A is principally due to stablization of transcriptional elongation.
Marciniak et al. (1990), Proc. Natl. Acad. Sci. USA, 87:3624-3628, Identification and characterization of a HeLa nuclear protein that specifically binds to the trans-activation-response (TAR) element of human immunodeficiency virus.
Garcia et al. (1987), The EMBO Journal, 6(12);3761-3770, Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus.
Gaynor et al. (1989), Proc. Natl. Acad. Sci. USA, 86:4858-4862, Specific binding of a HeLa cell nuclear protein to RNA sequences in the human immuodeficiency virus transactivating region.
Harrich et al. (1990), The EMBO Journal, 9(13):4417-4423, TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes.
Roy et al. (1990), Genes & Development, 4:1365-1373, A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat medicated trans-activation.
Pearson et al. (1990), Proc. Natl. Acad. Sci. USA, 87:5079-5083, A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.
Wu et al. (1988), The EMBO Journal, 7(7):2117-2129, Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1.
Dignam et al. (1983), Nucleic Acids Research, 11(5):1475-1488, Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.
Field et al. (1988), Molecular and Cellular Biology, 8(5):2159-2165, Purification of a RAS-Responsive Adenylyl Cyclase Complex from Saccharomyces cerevisiae by Use of an Epitope Addition Method.
Gatignol et al. (1989), Proc. Natl. Acad. Sci. USA, 86:7828-7832, Identification of cellular proteins that bind to the human immunodeficiency virus type 1 trans-activation-responsive TAR element RNA.
Goody et al. (1991), FEBS Letters (pp. 1-5), Factors contributing to the inhibition of HIV reverse transcriptase by the chain-terminating nucleotides in vitro and in vivo.
Calnan et al. (1991), Genes & Development, 5:201-210, Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition.
Gaynor (1991), Role of the TAR Element in Regulating HIV Gene Expression, In: Advances in Molecular Biology and Targeted Treatment of AIDS, pp. 79-90.
Gaynor, R. (1991), Cellular Factors Involved in Regulating HIV Gene Expression, In: Genetic Structure and Regulation of HIV, Haseltine and Wong-Staal, editors: pp. 107-134.
Waterman et al. (1991), Nuclear Proteins Implicated in HIV-1 Transcriptional Control, In: Genetic Structure and Regulation of HIV, Haseltine and Wong-Staal, editors: pp. 391-403.
Wu et al. (1991), Genes and Development, 5(11)1935-2152, tat Regulated Binding of the Human Immunodeficiency Virus Trans-Activating Region RNA Loop-Binding Protein TRP-185.
Sheline et al. (1991), Genes and Development, 5(12b):2508-2520, Two distinct nuclear transcription factors recognize loop and bulge residues of the HIV-1 TAR RNA hairpin.
Gaynor, R. (1992), AIDS, 6(4):347-363, Cellular transcription factors involved in the regulation of HIV-1 gene expression.
International Search Report, No. 92/09546.
Dialog Search Report (1991).
Gaynor Richard B.
Wu Foon K.
Board of Regents University of Texas
Nucker Christine M.
Stucker Jeffrey
LandOfFree
Cellular nucleic acid binding protein and uses thereof in regula does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cellular nucleic acid binding protein and uses thereof in regula, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cellular nucleic acid binding protein and uses thereof in regula will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1266533